首页> 外国专利> recombinant fusionsproteine based on ribosome - inactivating proteins of the mistletoe viscum album

recombinant fusionsproteine based on ribosome - inactivating proteins of the mistletoe viscum album

机译:槲寄生相册核糖体失活蛋白的重组融合蛋白。

摘要

The invention relates to nucleic acid molecules which encode fusion proteins which contain as components at least one effector module, a processing module and a targeting module. The nucleic acid molecules according to the invention preferably also encode a modulator module and/or an affinity module. The invention furthermore relates to vectors containing these nucleic acid molecules, hosts transformed with the vectors according to the invention, fusion proteins encoded by nucleic acids according to the invention or produced by the hosts according to the invention as well as to medicaments containing the polypeptides or vectors according to the invention. These medicaments are particularly significant for the therapy of diseases associated with a pathological reproduction and/or increased activity of cell populations. A temporary, periodic and strong proliferation, infiltration and immune activity of cells of the immune system is found in autoimmune diseases and allergies, the specificity of these immune cells being due to their reaction to a particular antigen or allergen. These medicaments may also be advantageously used for treating tumors. The polypeptides and vectors described in the present invention may be used to develop medicaments and to test toxin activity-modulating factors. The invention thus also concerns corresponding processes, uses and kits. The modules, with the exception of the affinity and the targeting module, are preferably encoded by nucleic acids extracted or derived from the mistletoe lectin proprotein coding sequence.
机译:本发明涉及编码融合蛋白的核酸分子,所述融合蛋白包含至少一个效应子模块,加工模块和靶向模块作为组分。根据本发明的核酸分子优选还编码调节剂模块和/或亲和力模块。本发明还涉及含有这些核酸分子的载体,用本发明的载体转化的宿主,由本发明的核酸编码的融合蛋白或由本发明的宿主产生的融合蛋白,以及含有该多肽或多肽的药物。根据本发明的载体。这些药物对于治疗与病理繁殖和/或细胞群活性增加有关的疾病特别重要。在自身免疫疾病和变态反应中发现了免疫系统细胞的暂时,周期性和强烈的增殖,浸润和免疫活性,这些免疫细胞的特异性是由于它们对特定抗原或变应原的反应。这些药物也可以有利地用于治疗肿瘤。本发明中描述的多肽和载体可以用于开发药物和测试毒素活性调节因子。因此,本发明还涉及相应的方法,用途和试剂盒。除亲和力和靶向模块外,模块优选地由从槲寄生凝集素前蛋白编码序列中提取或衍生的核酸编码。

著录项

  • 公开/公告号DE59811111D1

    专利类型

  • 公开/公告日2004-05-06

    原文格式PDF

  • 申请/专利权人 VISCUM AG;

    申请/专利号DE19985011111T

  • 发明设计人 ECK JUERGEN;SCHMIDT ARNO;ZINKE HOLGER;

    申请日1998-01-02

  • 分类号C12N15/62;C12N15/29;C07K19/00;C12P21/02;A61K35/78;A61K38/16;A61K47/48;C12Q1/68;

  • 国家 DE

  • 入库时间 2022-08-21 22:41:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号